Live
- IPL 2024: Fraser-McGurk, Porel fifties; Stubbs’ 41 propel DC to 221/8 against RR
- U20 men’s football nationals: Kerala beat Haryana to enter quarters; A.P. draw with Gujarat
- EPFO evaluating course of action over HC ruling on foreign workers
- Political slugfest surfaces in Bengal after SC puts interim stay on cancellation of 25,753 school jobs
- Apple launches iPad Pro with M4 chip and AI capabilities
- Congress stands for National unity says Arathi Krishna
- The dynamics of tax cuts and collections under Modi govt: A tale of prosperity
- ‘Inspiring to see the focus of sports expanding beyond cricket’: State-of-the-Art sports arena unveiled in Delhi
- Voltas Q4 net profit dips 19 per cent, declares dividend of Rs 5.50 per share
- Madigas should Vote for BJP to protect their self respect.Manda Krishna madiga
Sun Pharma posts Rs 1,064 crore Q2 net
Sun Pharmaceutical Industries on Thursday reported a consolidated net profit at Rs 1,064.09 crore in the second quarter ended September 30.
New Delhi: Sun Pharmaceutical Industries on Thursday reported a consolidated net profit at Rs 1,064.09 crore in the second quarter ended September 30.
The company had posted a consolidated net loss of Rs 269.6 crore in the same period last fiscal, Sun Pharma said in a regulatory filing.
Total revenue from operations during the period under review stood at Rs 8,123.35 crore as against Rs 6,937.63 crore in the year-ago quarter, it added.
During the quarter India sales were at Rs 2,515 crore, growth of 35 per cent over the second quarter last year, while the US finished dosage sales were at $339 million flat over the same period last year, the company said.
The sales in emerging markets were at $201 million, up by 3 per cent and that of the rest of world were at $161 million, a growth of 49 per cent.
Sun Pharma said its active pharmaceutical ingredients (API) clocked external sales of Rs 468 crore, up 10 per cent over the same quarter last fiscal.
